Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice

Nov-14

Pharmacoepidemiology

AUTHORS : Dr Gunnar Brobert, Epidemiology, Bayer AG, 13353 Berlin – Email: gunnar.brobert@bayer.com

JOURNAL : Value in Health

REFERENCE: 17(7):A473-A474

DOI : 10.1016/j.jval.2014.08.1350

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more